We are committed in providing a vast variety of 2mg Bortezomib Injection IP. It is used to treat multiple myeloma in patients with or without a previous history of treatment. This injection is also given to those who have received at least one prior therapy. Bortezomib 2MG Injection IP is also useful to treat cancer of the bone marrow in combination with other medications for people. It is antineoplastic agent to kill cancer cells.
Specification
Medicine Type |
Allopathic |
Form |
Injection |
Also Gives |
PCD Pharma Franchise |
Usage |
Clinical,Hospital,Personal |
Dose/Strength (ex. 1 mg or 1 ml) |
2 mg |
Manufacturer |
Cadila Healthcare (Zydus) |
Composition |
Bortezomib |
Packaging Type |
Box |
Packaging Size |
1 Vial |